Company news

Bio-Techne Corp news in 2022

Bio-Techne Corp's news releases, calls and decks from 2022, newest first.

View company

Bio-Techne to present at the 41st annual j.p. morgan healthcare conference

December 20, 2022

Bio-Techne releases MitoBrilliant™ fluorescent dyes, providing a next-generation tool for imaging mitochondria in live and fixed cells

December 4, 2022

Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market

November 30, 2022

BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE

November 27, 2022

Namocell highlighted in nature publication for efficient single cell cloning of human pluripotent stem cells

November 16, 2022

Bio-Techne announces opening of new immunoassay manufacturing facility

November 14, 2022

Bio-Techne to present at the stephens annual investment conference

November 9, 2022

Bio-Techne to present at the stifel 2022 healthcare conference

November 7, 2022

Bio-Techne to present at the credit suisse 31st annual healthcare conference

November 2, 2022

Bio-Techne releases first quarter fiscal 2023 results

October 31, 2022

Bio-Techne declares cash dividend and stock dividend

October 31, 2022

New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

October 17, 2022

Bio-Techne sets a new standard in highly sensitive RNA imaging with the introduction of vivid fluorescent dyes for spatial biology

October 11, 2022

Bio-Techne introduces new Simple Plex AAV viral titer assays

October 10, 2022

Bio-Techne to host conference call on November 1, 2022, to announce first quarter 2023 financial results

October 9, 2022

Bio-Techne commercializes automated multi-omic RNAscope assays for spatial visualization of RNA and protein biomarkers in ffpe tissues

October 5, 2022

Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments

September 25, 2022

Bio-Techne issues 2022 corporate sustainability report

September 18, 2022

Bio-Techne presents initial data on Sjögren's Syndrome monitoring assay

September 7, 2022

Bio-Techne to seek approval to implement four-for-one stock split

August 31, 2022

Bio-Techne announces release of Quantist Luminex® data analysis software

August 17, 2022

Bio-Techne announces CEO transition plan

August 3, 2022

Bio-Techne announces licensing agreement and partnership with University of Dundee

July 27, 2022

Bio-Techne to host conference call on August 4, 2022, to announce fourth quarter 2022 financial results

July 13, 2022

Bio-Techne launches new Turbo CE-SDS™ cartridge, accelerating protein purity analysis throughput by 400%

July 11, 2022

Bio-Techne Announces Launch of the CE-IVD RNAscope™ ISH Probe High Risk HPV Assay for Head and Neck Cancer

July 5, 2022

Bio-Techne announces completion of Namocell acquisition

July 4, 2022

Bio-Techne to acquire Namocell

June 21, 2022

Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

May 25, 2022

Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder Cancer Test

May 11, 2022

Bio-Techne releases third quarter fiscal 2022 results

May 3, 2022

Bio-Techne to host conference call on May 4, 2022, to announce third quarter 2022 financial results

April 12, 2022

Bio-Techne and Cygnus Technologies, part of Maravai LifeSciences, introduce new Simple Plex HEK 293 HCP 3G immunoassay

April 11, 2022

Bio-Techne announces exclusive development and license agreement with Thermo Fisher Scientific for ExoTRU® kidney transplant rejection assay

February 21, 2022

Bio-Techne announces publication of new data demonstrating ExoDx prostate test correlation with post-prostatectomy pathology outcomes

February 13, 2022

Bio-Techne releases second quarter fiscal 2022 results

January 31, 2022

Bio-Techne announces commercial release of high sensitivity fluorescent detection Stellar nir / IR™ Modules for Jess automated western blotting system

January 17, 2022

Bio-Techne to host conference call on February 1, 2022 to announce second quarter 2022 financial results

January 16, 2022

Bio-Techne announces updated presentation time at the j.p. morgan healthcare conference

January 6, 2022

Calls in 2022

Decks in 2022